/CPMD
CPMD Stock - CannaPharmaRX, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00-2.00%
$0.00 (-2.00%) • Dec 19
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.94
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CPMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.01
STOP LOSS$0.00
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.51
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $820,137 | N/A | N/A | N/A | N/A |
| Gross Profit | $-2,935,000 | $-65,561 | $-295,000 | $-14,364 | $-129,000 |
| Gross Margin | -357.9% | N/A | N/A | N/A | N/A |
| Operating Income | $-3,606,000 | $-1,581,000 | $-5,212,000 | $-2,993,000 | $-14,486,000 |
| Net Income | $-9,906,000 | $3.69M | $-8,531,000 | $-8,832,000 | $-19,890,000 |
| Net Margin | -1207.8% | N/A | N/A | N/A | N/A |
| EPS | $-0.02 | $0.01 | $-0.04 | $-0.12 | $-0.49 |
Company Overview
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CPMDBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 16, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 10, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 13, 2024 | — | $0.00 | — | — |
Q3 2024 | Aug 14, 2024 | — | $0.01 | — | — |
Q2 2024 | Jun 25, 2024 | — | $-0.03 | — | — |
Q2 2024 | May 16, 2024 | — | $0.02 | — | — |
Q4 2023 | Nov 17, 2023 | — | $-0.00 | — | — |
Q4 2023 | Oct 13, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 22, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 1, 2023 | — | $-0.02 | — | — |
Q4 2022 | Nov 22, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 22, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 24, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.10 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 17, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 17, 2021 | — | $0.02 | — | — |
Q2 2021 | Apr 14, 2021 | — | $-0.29 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CPMD
What is CPMD's current stock price?
CannaPharmaRX, Inc. (CPMD) is currently trading at $0.00 per share. The stock has moved -2.00% today.
What is the analyst price target for CPMD?
No analyst price targets are currently available for this stock.
What sector is CannaPharmaRX, Inc. in?
CannaPharmaRX, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CPMD's market cap?
CannaPharmaRX, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CPMD pay dividends?
No, CannaPharmaRX, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALID
Allied Corp.
$0.00
Mkt Cap: $0.0B
APPB
Applied Biosciences Corp.
$0.00
Mkt Cap: $0.0B
CBDY
Target Group Inc.
$0.00
Mkt Cap: $0.0B
CNNA
Cann American Corp.
$0.00
Mkt Cap: $0.0B
EXMT
Anything Technologies Media, Inc.
$0.00
Mkt Cap: $0.0B
LVVEF
Yooma Wellness Inc.
$0.00
Mkt Cap: $0.0B
MJARF
MJardin Group, Inc.
$0.00
Mkt Cap: $0.0B
MSTH
Mystic Holdings, Inc.
$0.01
Mkt Cap: $0.0B
PLSH
Panacea Life Sciences Holdings, Inc.
$0.09
Mkt Cap: $0.0B
SRUTF
Sproutly Canada Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to CPMD for comparison